SU878297A1 - Состав дл сохранени жизнеспособности оперируемого сердца - Google Patents

Состав дл сохранени жизнеспособности оперируемого сердца Download PDF

Info

Publication number
SU878297A1
SU878297A1 SU782637452A SU2637452A SU878297A1 SU 878297 A1 SU878297 A1 SU 878297A1 SU 782637452 A SU782637452 A SU 782637452A SU 2637452 A SU2637452 A SU 2637452A SU 878297 A1 SU878297 A1 SU 878297A1
Authority
SU
USSR - Soviet Union
Prior art keywords
heart
asparaginate
operated
sodium
vitality
Prior art date
Application number
SU782637452A
Other languages
English (en)
Inventor
Валерий Иванович Шумаков
Нина Андреевна Онищенко
Владимир Игоревич Кирпатовский
Александр Анатольевич Лубяко
Михаил Александрович Данилов
Татьяна Алексеевна Богоявленская
Борис Петрович Расторгуев
Original Assignee
Научно-Исследовательский Институт Трансплантологии И Искусственных Органов
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Научно-Исследовательский Институт Трансплантологии И Искусственных Органов filed Critical Научно-Исследовательский Институт Трансплантологии И Искусственных Органов
Priority to SU782637452A priority Critical patent/SU878297A1/ru
Application granted granted Critical
Publication of SU878297A1 publication Critical patent/SU878297A1/ru

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Description

0,360-0,364
0,438-0,442
0,388-0,402
0,018-0,022
0,068-0,072
0,00098-0,00102
0,100196-0,00204
0,248-0,252
16,5-17,5 0,020-0,025 Остальное
Источник «нфармадни, «прин тый во внимание лри эксперглизе:
1. Раствор Бредшнейдера (Verh Dtsch ges. Kreise -Forgch), 1964, 30.11.34.

Claims (1)

  1. Формула изобретения
    Состав для сохранения жизнеспособности оперируемого сердца, содержащий глюкозу, манитол и воду, отличающийся тем, что, с целью увеличения сроков жизне25 способности сердца, он дополнительно содержит ацетат калия, аспарагинат калия, аспарагинат магния, сукцинат натрия, бикарбонат натрия, натриевую соль АТФ, лидокаин и гепарин при следующем соотно30 шении компонентов, вес. %:
    Ацетат калия 0,360—0,364 Маннитол 16,5—17,5 Аспарагинат калия 0,438—0,442 Гепарин 0,020—0,025 Аспарагинат магния 0,388—0,402 Вода Остальное Сукцинат натрия 0,018—0,022 Бикарбонат натрия 0,068—0,072 5 Источник информации, принятый во Натриевая соль АТФ 0,00098—0,00102 внимание при экспертизе: Лидокаин 0,00196—0,00204 1. Раствор Бредшнейдера (Verh Dtsch Глюкоза 0,248—0,252 ges. Kreise — Forgch), 1964, 30.11.34.
SU782637452A 1978-05-03 1978-05-03 Состав дл сохранени жизнеспособности оперируемого сердца SU878297A1 (ru)

Priority Applications (1)

Application Number Priority Date Filing Date Title
SU782637452A SU878297A1 (ru) 1978-05-03 1978-05-03 Состав дл сохранени жизнеспособности оперируемого сердца

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SU782637452A SU878297A1 (ru) 1978-05-03 1978-05-03 Состав дл сохранени жизнеспособности оперируемого сердца

Publications (1)

Publication Number Publication Date
SU878297A1 true SU878297A1 (ru) 1981-11-07

Family

ID=20773949

Family Applications (1)

Application Number Title Priority Date Filing Date
SU782637452A SU878297A1 (ru) 1978-05-03 1978-05-03 Состав дл сохранени жизнеспособности оперируемого сердца

Country Status (1)

Country Link
SU (1) SU878297A1 (ru)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5407793A (en) * 1991-10-18 1995-04-18 University Of Pittsburgh Of The Commonwealth System Of Higher Education An aqueous heart preservation and cardioplegia solution
WO2002045705A3 (en) * 2000-12-08 2003-10-16 Pieter Theo Ernst Regenaration of blood vessels
WO2004000331A1 (en) * 2002-06-21 2003-12-31 Global Cardiac Solutions Pty Ltd Organ arrest, protection, preservation and recovery
US6955814B1 (en) 1999-03-23 2005-10-18 Global Cardiac Solutions Pty Ltd. Organ arrest, protection and preservation
US8946189B2 (en) 2007-03-02 2015-02-03 Hibernation Therapeutics, A Kf Llc Transplants
US9125929B2 (en) 2006-07-25 2015-09-08 Hibernation Therapeutics, A Kf Llc Trauma therapy
US10251905B2 (en) 2006-05-29 2019-04-09 Hibernation Therapeutics, A Kf Llc Tissue maintenance
US10786525B2 (en) 2013-07-17 2020-09-29 Hibernation Therapeutics A Kf Llc Method for treating haemorrhage, shock and brain injury

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5407793A (en) * 1991-10-18 1995-04-18 University Of Pittsburgh Of The Commonwealth System Of Higher Education An aqueous heart preservation and cardioplegia solution
US9320753B2 (en) 1999-03-23 2016-04-26 Hibernation Therapeutics, A Kf Llc Organ arrest, protection and preservation
US7749522B2 (en) 1999-03-23 2010-07-06 Hibernation Therapeutics Limited Organ arrest, protection and preservation
US6955814B1 (en) 1999-03-23 2005-10-18 Global Cardiac Solutions Pty Ltd. Organ arrest, protection and preservation
WO2002045705A3 (en) * 2000-12-08 2003-10-16 Pieter Theo Ernst Regenaration of blood vessels
AU2003232526B2 (en) * 2002-06-21 2010-07-01 Hibernation Therapeutics, A Kf Llc Organ arrest, protection, preservation and recovery
GB2407503B (en) * 2002-06-21 2006-12-27 Global Cardiac Solutions Pty L Organ arrest, protection, preservation and recovery
GB2407503A (en) * 2002-06-21 2005-05-04 Global Cardiac Solutions Pty L Organ arrest, protection, preservation and recovery
AU2010226894B2 (en) * 2002-06-21 2011-07-07 Hibernation Therapeutics, A Kf Llc Organ arrest, protection, preservation and recovery
WO2004000331A1 (en) * 2002-06-21 2003-12-31 Global Cardiac Solutions Pty Ltd Organ arrest, protection, preservation and recovery
US10251905B2 (en) 2006-05-29 2019-04-09 Hibernation Therapeutics, A Kf Llc Tissue maintenance
US9125929B2 (en) 2006-07-25 2015-09-08 Hibernation Therapeutics, A Kf Llc Trauma therapy
US8946189B2 (en) 2007-03-02 2015-02-03 Hibernation Therapeutics, A Kf Llc Transplants
US10786525B2 (en) 2013-07-17 2020-09-29 Hibernation Therapeutics A Kf Llc Method for treating haemorrhage, shock and brain injury

Similar Documents

Publication Publication Date Title
Ultsch et al. Long-term submergence at 3 C of the turtle, Chrysemys picta bellii, in normoxic and severely hypoxic water: I. Survival, gas exchange and acid-base status
Opie et al. Effect of glucose-insulin-potassium infusions on arteriovenous differences of glucose and of free fatty acids and on tissue metabolic changes in dogs with developing myocardial infarction
SU878297A1 (ru) Состав дл сохранени жизнеспособности оперируемого сердца
KORNBLUETH et al. Glucose utilization of the retina: Influence of various media
ES8203224A1 (es) Procedimiento de preparacion de globulos rojos concentrados para almacenamiento.
Guder et al. The diagnostic significance of liver cell inhomogeneity: serum enzymes in patients with central liver necrosis and the distribution of glutamate dehydrogenase in normal human liver
EA200000058A1 (ru) Лечение посредством блокады cd154 при трансплантации ткани панкреатических островков
ES470069A1 (es) Procedimiento para la produccion de un preparado enzimatico
Stock Aspects of approaches in experimental cancer chemotherapy
Taylor et al. Membrane (contact) digestion in the three species of tapeworm Hymenolepis diminuta, Hymenolepis microstoma and Moniezia expansa
DER LAARSE et al. Release of alpha hydroxybutyrate from neonatal rat heart cell cultures exposed to anoxia and reoxygenation: comparison with impairment of structure and function of damaged cardiac cells
Bryan Jr et al. Cerebral energy metabolism in diving and non‐diving birds during hypoxia and apnoeic asphyxia.
Warburg The evaporative water loss of three isopods from semi-arid habitats in South Australia
TAGUCHI et al. Enzymatic responses and adaptations to swimming training and hypobaric hypoxia in postnatal rats
NO891220L (no) Middel som inneholder salicylsyre for behandling av lepidose.
Watten et al. Comparison of acetate, lactate, and bicarbonate in treating the acidosis of cholera
Modigh et al. Mitochondrial respiration in the ventricular myocardium and in the white and deep red myotomal muscles of juvenile tuna fish (Thunnus thynnus L.)
Almeida et al. Relapse rates in lepromatous leprosy according to treatment regularity.
Barr et al. Inclusion cyst of the myocardium in a patient with complete heart block.
Elliott Biological oxidation-reduction catalysts
Verel et al. Circulatory adjustments of voluntary muscle in anemia
Kalous et al. Oxidative metabolism of the inner and outer ventricular layers of carp heart (Cyprinus carpio L.)
Roth et al. The effect of dimethyl sulfoxide on rat skin oxygen utilization
GRAS OXIDATIVE CAPACITY OF THE LATERAL MUSCLE OF THE BREEDING FARM RAINBOW TROUT(SALMO GAIRDNERII RICHARDSON)
Marek Morphological changes in the myocardium as substrate of “functional asymmetry” in sudden death